Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

USTEKINUMAB for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 21,763 adverse event reports in the FDA FAERS database where USTEKINUMAB was used for Psoriasis.

Most Reported Side Effects for USTEKINUMAB

Side Effect Reports % Deaths Hosp.
Drug ineffective 12,471 14.6% 990 2,509
Off label use 10,990 12.9% 1,395 2,924
Product dose omission issue 9,405 11.0% 5 214
Fatigue 5,457 6.4% 1,492 2,135
Product use issue 5,008 5.9% 729 1,670
Psoriasis 4,955 5.8% 361 954
Pain 4,872 5.7% 1,342 1,993
Rash 4,736 5.6% 1,499 2,072
Crohn's disease 4,662 5.5% 404 1,625
Arthralgia 4,608 5.4% 1,331 1,992
Infusion related reaction 4,471 5.2% 1,518 2,009
Condition aggravated 4,366 5.1% 1,225 1,853
Headache 4,179 4.9% 1,217 1,729
Rheumatoid arthritis 4,047 4.7% 1,497 2,041
Hypersensitivity 3,937 4.6% 1,358 1,840

Other Indications for USTEKINUMAB

Product used for unknown indication (26,638) Crohn's disease (22,537) Psoriatic arthropathy (5,909) Colitis ulcerative (3,872) Rheumatoid arthritis (2,373) Inflammatory bowel disease (470) Ankylosing spondylitis (247) Colitis (219) Hidradenitis (188) Pustular psoriasis (120)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628) HUMIRA (6,346)

Related Pages

USTEKINUMAB Full Profile All Psoriasis Drugs USTEKINUMAB Demographics USTEKINUMAB Timeline